SCHEMBL1316970

SCHEMBL1316970

CC(=O)c1ccc(F)c(N(C)C(C)=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FSCN1 Q16658 1/20 0.46
MAOB P27338 2/20 0.39
MAOA P21397 1/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
KIF11 P52732 1/20 0.38
MAPT P10636 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2A6 P11509 1/20 0.37
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.36
TSPO P30536 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPK1 P28482 1/20 0.35
PRKCI P41743 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7894279 0.86 FSCN1 (0.44) FSCN1MAOBMAOACES2CES1
SCHEMBL1545185 0.80 PKM (0.49) FSCN1MAPTNPC1RAB9AALDH1A1
SCHEMBL1316220 0.80 CYP1A2 (0.56) MAPTNPC1RAB9AALDH1A1MEN1
SCHEMBL1316217 0.80 CYP1A2 (0.56) MAPTNPC1RAB9AALDH1A1MEN1
SCHEMBL3253845 0.78 KMT2A (0.45) MAPTRAB9AALDH1A1MEN1KMT2A
SCHEMBL15047117 0.78 CYP1A2 (0.43) FSCN1MAPTNPC1RAB9AALDH1A1
SCHEMBL13547957 0.76 FSCN1 (0.44) FSCN1MAPTNPC1RAB9AALDH1A1
SCHEMBL29669896 0.74 CES2 (0.67) MAOBMAOACES2CES1KIF11
SCHEMBL75801 0.74 CES2 (0.67) MAOBMAOACES2CES1KIF11
SCHEMBL8782702 0.74 MAPT (0.46) MAOBCES2CES1KIF11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387557-B1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM SA (ES) 2013-06-19 EP claimed
US-8163903-B2 Process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide INTERQUIM, S.A. (ES) 2012-04-24 US claimed
EP-2387557-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE Interquim, S.A. (ES) 2011-11-23 EP claimed
US-20110275809-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM, S.A. (ES) 2011-11-10 US claimed
US-20110254078-A1 METHOD FOR DEPOSITING SILICON NITRIDE FILM, COMPUTER-READABLE STORAGE MEDIUM, AND PLASMA CVD DEVICE TOKYO ELECTRON LIMITED (JP) 2011-10-20 US claimed
WO-2010081788-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM, S.A. (ES) 2010-07-22 WO claimed
EP-2387557-B1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM SA (ES) 2013-06-19 EP disclosed
US-8163903-B2 Process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide INTERQUIM, S.A. (ES) 2012-04-24 US disclosed
US-8163903-B2 Process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide INTERQUIM, S.A. (ES) 2012-04-24 US disclosed
US-8163903-B2 Process for the preparation of N-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-N-methyl-acetamide INTERQUIM, S.A. (ES) 2012-04-24 US disclosed
CN-102282123-A Process for the preparation of N- [5- (3-dimethylamino-acryloyl) -2-fluoro-phenyl ] -N-methyl-acetamide 2011-12-14 CN disclosed
EP-2387557-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE Interquim, S.A. (ES) 2011-11-23 EP disclosed
US-20110275809-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM, S.A. (ES) 2011-11-10 US disclosed
US-20110275809-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM, S.A. (ES) 2011-11-10 US disclosed
US-20110275809-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM, S.A. (ES) 2011-11-10 US disclosed
US-20110254078-A1 METHOD FOR DEPOSITING SILICON NITRIDE FILM, COMPUTER-READABLE STORAGE MEDIUM, AND PLASMA CVD DEVICE TOKYO ELECTRON LIMITED (JP) 2011-10-20 US disclosed
WO-2010081788-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM, S.A. (ES) 2010-07-22 WO disclosed
WO-2010081788-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE INTERQUIM, S.A. (ES) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275809-A1 PROCESS FOR THE PREPARATION OF N-[5-(3-DIMETHYLAMINO-ACRYLOYL)-2-FLUORO-PHENYL]-N-METHYL-ACETAMIDE GABRA5, GABRA6, GABRD FSCN1 4410/4885MAOB 763/4885MAOA 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.